Friends of Cancer Research (Friends) is hosting a meeting focused on driving innovation in diagnostics and regulatory policy, featuring an opening keynote by Dr. Michelle Tarver, Director of the FDA Center for Devices and Radiological Health (CDRH).

Key discussions will highlight evidence generation for novel technologies for diagnostic testing, including digital pathology and artificial intelligence (AI), along with strategies for developing diagnostic tests for rare biomarkers and addressing future regulatory considerations for cutting-edge tools. New data will also be released from the ongoing Digital PATH Project, which leveraged a common dataset to evaluate variability across digital pathology platforms. This meeting brings together key thought leaders to explore how these innovations can accelerate progress in precision medicine and improve patient outcomes.